The old beats the new - direct oral anticoagulants in severe antiphospholipid syndrome?

被引：0
|
作者：
Bloedt, Kathrin [1 ]
Imhof, Armin [1 ]
机构：
[1] Univ Klinikum Ulm, Klin Innere Med 2, Ulm, Germany
来源：
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE | 2020年 / 49卷 / 01期
关键词：
D O I：
10.1024/0301-1526/a000828
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [31] Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials
    Dufrost, Virginie
    Wahl, Denis
    Zuily, Stephane
    AUTOIMMUNITY REVIEWS, 2021, 20 (01)
  • [32] Comparative Analysis of Direct Oral Anticoagulants and Vitamin K Antagonists in Antiphospholipid Syndrome Patients
    Elsebaie, Maha A. T.
    Wickham, Zoe Alexandra
    Debragga, Stephanie
    Li, Juan
    Gaddh, Manila
    BLOOD, 2021, 138
  • [33] Direct oral anticoagulants in thrombotic antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension
    Porres-Aguilar, Mateo
    Kahn, Susan R.
    Hirsch, Andrew M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (03) : 755 - 756
  • [34] Rethinking the use of direct oral anticoagulants for secondary thromboprophylaxis in patients with thrombotic antiphospholipid syndrome
    Franco-Moreno, Anabel
    Izquierdo-Martinez, Aida
    Ancos-Aracil, Cristina
    DRUG DISCOVERIES AND THERAPEUTICS, 2024, 18 (04): : 213 - 219
  • [35] Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)
    Moreira Balbi, Gustavo Guimaraes
    Pacheco, Marcelo de Souza
    Monticielo, Odirlei Andre
    Funke, Andreas
    Danowski, Adriana
    Santiago, Mittermayer Barreto
    Staub, Henrique Luiz
    Rego, Jozelia
    Oliveira de Andrade, Danieli Castro
    ADVANCES IN RHEUMATOLOGY, 2020, 60 (01)
  • [36] Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)
    Gustavo Guimarães Moreira Balbi
    Marcelo de Souza Pacheco
    Odirlei Andre Monticielo
    Andreas Funke
    Adriana Danowski
    Mittermayer Barreto Santiago
    Henrique Luiz Staub
    Jozelia Rêgo
    Danieli Castro Oliveira de Andrade
    Advances in Rheumatology, 60
  • [37] Oral anticoagulants - The old and the new
    Ansell, J
    DM DISEASE-A-MONTH, 2005, 51 (2-3): : 208 - 212
  • [38] Direct Oral Anticoagulants in Antiphospholipid Syndrome-Associated Venous Thromboembolism: Real World Evidence
    Hwang, Hun-Gyu
    Lee, Ju Hyun
    Kim, Sang-A
    Kim, Yang-Ki
    Kim, Myung-Shin
    Hong, Junshik
    Yhim, Ho-Young
    Bang, Soo-Mee
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (36)
  • [39] Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.
    Cerda, Pau
    Becattini, Cecilia
    Iriarte, Adriana
    Hernandez, Josefina Cortes
    Corbella, Xavier
    Riera-Mestre, Antoni
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 79 : 43 - 50
  • [40] Successful secondary thromboprophylaxis with direct oral anticoagulants for a patient with catastrophic antiphospholipid syndrome A case report
    Nhan Hieu Dinh
    Beaupha, Suzanne Monivong Cheanh
    MEDICINE, 2020, 99 (26) : E20811
12345